Insider Trading & Ownership of Atlas Venture Fund XI, L.P.

Location
Cambridge, MA
Summary
The estimated value of insider holdings of Atlas Venture Fund XI, L.P. is at least $389M dollars as of 10 Feb 2025. Atlas Venture Fund XI, L.P. is the 10%+ Owner of Dyne Therapeutics, Inc. and owns shares of Dyne Therapeutics, Inc. (DYN) stock worth about $166M. Atlas Venture Fund XI, L.P. is the 10%+ Owner of Third Harmonic Bio, Inc. and owns shares of Third Harmonic Bio, Inc. (THRD) stock worth about $140M. Atlas Venture Fund XI, L.P. is the 10%+ Owner of Day One Biopharmaceuticals, Inc. and owns shares of Day One Biopharmaceuticals, Inc. (DAWN) stock worth about $70.2M. Atlas Venture Fund XI, L.P. is the 10%+ Owner of Ikena Oncology, Inc. and owns shares of Ikena Oncology, Inc. (IKNA) stock worth about $11.4M. Atlas Venture Fund XI, L.P. is the 10%+ Owner of Xilio Therapeutics, Inc. and owns shares of Xilio Therapeutics, Inc. (XLO) stock worth about $1.76M.
Signature
Atlas Venture Fund XI, L.P., By: Atlas Venture Associates XI, L.P., its general partner, by Atlas Venture Associates XI, LLC, its general partner, By: /s/ Ommer Chohan, Chief Financial Officer
All Insider Reports
All Insider Reports

Notify me when Atlas Venture Fund XI, L.P. files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Atlas Venture Fund XI, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
DYN Dyne Therapeutics, Inc. 10%+ Owner $166M 26 Feb 2024
THRD Third Harmonic Bio, Inc. 10%+ Owner $140M 01 Nov 2024
DAWN Day One Biopharmaceuticals, Inc. 10%+ Owner $70.2M 12 Dec 2022
IKNA Ikena Oncology, Inc. 10%+ Owner $11.4M 30 Mar 2021
XLO Xilio Therapeutics, Inc. 10%+ Owner $1.76M 08 Feb 2024
SION Sionna Therapeutics, Inc. 10%+ Owner 10 Feb 2025

Insider Transactions Reported by Atlas Venture Fund XI, L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.